By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Catalyst Pharmaceutical Partners, Inc. 

355 Alhambra Circle, Suite 1500

Coral Gables  Florida  33134  U.S.A.
Phone: 305-529-2522 Fax: 305-529-0933



Company News
Catalyst Pharmaceuticals (CPRX) Must Run Another Study of Its Firdapse Drug: FDA 4/26/2016 7:16:27 AM
Catalyst Pharmaceuticals (CPRX) Announces Fourth Quarter And Year-End 2015 Financial Results 3/16/2016 8:19:34 AM
Catalyst Pharmaceuticals (CPRX)To Present At The 28th Annual ROTH Conference 3/10/2016 1:54:17 PM
Catalyst Pharmaceuticals (CPRX) To Hold Fourth Quarter Financial Results Conference Call And Webcast On Wednesday, March 16th, 2016 3/9/2016 8:06:03 AM
Catalyst Pharmaceuticals (CPRX) Appoints Brian Elsbernd As Senior Vice President Of Legal And Compliance 2/26/2016 7:58:11 AM
Catalyst Pharmaceuticals (CPRX) Announces Participation At SunTrust Robinson Humphrey’s 2016 Orphan Drug Day 2/18/2016 1:29:34 PM
Catalyst Pharmaceuticals (CPRX) Tanks on FDA Refuse-to-File Letter 2/17/2016 6:27:50 AM
Catalyst Pharmaceuticals (CPRX) Announces Initiation Of Investigator-Sponsored Study Of Firdapse In Patients With Musk-Antibody Positive Myasthenia Gravis 2/8/2016 7:35:46 AM
Catalyst Pharmaceuticals (CPRX) To Present At The 18th Annual BIO CEO & Investor Conference 2/4/2016 7:55:46 AM
Catalyst Pharmaceuticals (CPRX) Completes NDA Submission To FDA For Firdapse For The Treatment Of Lambert-Eaton Myasthenic Syndrome And Congenital Myasthenic Syndromes 12/17/2015 7:59:30 AM